Tools
Dietary Therapy for LDL Cholesterol Reduction: Evidence-Based Patterns for Cardiovascular Risk Management
Introduction
Dyslipidemia, including elevated total and low-density lipoprotein cholesterol (LDL-C), hypertriglyceridemia, and elevated lipoprotein(a), affects approximately 20% to 30% of the global population. In the United States, about 25% of adults have an LDL-C level of 130 mg/dL or higher.[1][2] Dyslipidemias are major contributors to cardiovascular disease, the leading cause of mortality worldwide.
Across the lifespan, nutrition influences lipid metabolism, systemic inflammation, insulin sensitivity, and vascular health, underscoring the importance of nutrition regardless of whether pharmacologic therapy is ultimately required. Contemporary guidance has shifted from focusing on dietary cholesterol alone to prioritizing overall dietary patterns, fat quality, fiber intake, and whole-food sources. A healthy diet, as described in the 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease, carries a Class I recommendation for reducing cardiovascular disease (CVD) events.[3][4] Nutrition therapy is a foundational nonpharmacologic strategy for managing dyslipidemias and for reducing the risk of atherosclerotic cardiovascular disease (ASCVD) and broader cardiometabolic complications.
The National Lipid Association emphasizes that the main targets of nutrition interventions are LDL-C and non–high-density lipoprotein-C, which serve as surrogates for circulating atherogenic apoB-containing lipoprotein particles.[5] Accumulating evidence shows that saturated fat intake, the macronutrients and foods that replace it, and the degree of food processing have a greater impact on LDL-C levels and cardiovascular outcomes than dietary cholesterol alone. As a result, modern dietary recommendations prioritize replacing saturated fats from sources such as butter, full-fat dairy, fatty meats, and tropical oils with unsaturated fats from plant oils, nuts, seeds, and fish; eliminating industrially produced trans fats; and emphasizing fiber-rich, minimally processed foods, rather than targeting cholesterol intake as a primary goal. Dietary therapy is appropriate both as first-line management for individuals with mild to moderate LDL-C elevation and as an adjunct to lipid-lowering medications in higher-risk populations.
Professional guidance from major organizations, including the American College of Cardiology (ACC), the American Heart Association (AHA), and the Dietary Guidelines for Americans, consistently supports dietary patterns that reduce ASCVD risk. These include the Mediterranean diet, the Dietary Approaches to Stop Hypertension (DASH) diet, plant-based and vegetarian dietary patterns, and the dietary portfolio approach, all of which emphasize high-quality fats, high fiber intake, and minimally processed foods. Core recommendations include limiting saturated fat intake, replacing saturated fats with monounsaturated and polyunsaturated fats, and increasing consumption of fiber-rich foods, including vegetables, fruits, legumes, whole grains, nuts, and seeds.
This topic focuses on dietary strategies for the prevention and management of dyslipidemia. Pharmacologic approaches to hypercholesterolemia are addressed elsewhere in this series. Please see StatPearls companion topics "Hypercholesterolemia," "Hypertriglyceridemia," and "Familial Hypertriglyceridemia" for further discussion on the pharmacologic management of specific dyslipidemias.
Issues of Concern
Register For Free And Read The Full Article
Search engine and full access to all medical articles- 10 free questions in your specialty
- Free CME/CE Activities
- Free daily question in your email
- Save favorite articles to your dashboard
- Emails offering discounts
Learn more about a Subscription to StatPearls Point-of-Care
Issues of Concern
Implementing dietary therapy for dyslipidemia is challenging, owing to confusion about recommended diets, difficulty with adherence, and modest reductions in LDL-C compared with medications.
Outdated Focus on Dietary Cholesterol
The 2006 AHA Diet and Lifestyle Recommendations limited dietary cholesterol to less than 300 mg/day.[6] A pivotal shift began with the 2015 to 2020 Dietary Guidelines for Americans, which removed the specific 300 mg/day cholesterol restriction. The AHA clarified this change in its 2020 Science Advisory on Dietary Cholesterol and Cardiovascular Risk, noting that although recent guidelines had moved away from explicit numerical cholesterol targets, individuals should not increase their dietary cholesterol intake.[7] The advisory acknowledged that dietary cholesterol raises LDL-C in a dose-dependent manner—meta-analyses show that each 100 mg/day increase in dietary cholesterol raises LDL-C by approximately 1.93 mg/dL.[8] However, the effect is modest compared with that of saturated fat, and isolating the independent impact of cholesterol is complicated by its co-occurrence with saturated fat in foods such as eggs, bacon, sausage, and processed foods.[7]
A persistent misconception is that lowering dietary cholesterol alone is sufficient to reduce serum LDL-C. Contemporary evidence indicates that although dietary cholesterol raises LDL-C levels in most individuals, endogenous cholesterol synthesis, regulated by hepatic metabolism and influenced by saturated fat intake, plays a substantially larger role in determining serum LDL-C levels. Controlled dietary intervention studies and meta-analyses consistently show that saturated fat intake and overall dietary pattern exert a far greater influence on LDL-C than dietary cholesterol. Consequently, foods traditionally characterized as high in cholesterol, such as eggs, may have variable effects on LDL-C that depend on the overall dietary pattern and the accompanying intake of saturated fats and refined carbohydrates. Continued emphasis on cholesterol restriction alone may divert attention from more impactful dietary targets, including fat quality, fiber intake, and whole-food rather than processed-food choices.[9]
Nutrient-Centric Versus Pattern-Based Counseling
Overemphasis on cholesterol or total fat can inadvertently lead patients to choose ultra-processed "cholesterol-free" or "low-fat" foods that are high in refined carbohydrates and added sugars, or that contain plant-based saturated fats. Such substitutions may confer no cardiometabolic benefit and may increase risk. Pattern-based counseling emphasizes whole-food combinations that consistently improve lipid profiles and cardiovascular outcomes. Dietary patterns rich in vegetables, fruits, whole grains, legumes, nuts, seeds, and unsaturated fats lower LDL-C through multiple mechanisms, including reducing saturated fat intake and increasing soluble fiber, while also improving insulin sensitivity and overall cardiometabolic health.[10]
| Pause and Reflect | A 58-year-old patient with an LDL-C of 155 mg/dL asks whether simply avoiding eggs and other cholesterol-rich foods will sufficiently lower cardiovascular risk. Based on the evidence presented, how should the clinician counsel this patient? |
Inconsistent Interpretation of Popular Dietary Patterns
Considerable confusion exists about the cardiovascular effects of popular dietary patterns, including the Mediterranean, DASH, plant-based, and low-carbohydrate diets. Public messaging on eggs, dairy, red meat, and dietary fats is often inconsistent, making it difficult to determine which recommendations are evidence-based. Although multiple dietary patterns are associated with reductions in LDL-C, the magnitude and reliability of these effects vary with diet composition and outcome measures. The Mediterranean, DASH, plant-based, and vegetarian diets reduce LDL-C primarily by lowering saturated fat intake and increasing fiber intake. However, adherence and sustainability vary.[11] Low-carbohydrate diets have variable effects depending on whether people replace carbohydrates with higher amounts of saturated fat.
Notably, replacing saturated fat with average-quality carbohydrates lowers LDL-C by only 0.21 mmol/L while increasing triglycerides by 0.17 mmol/L, resulting in a neutral effect on cardiovascular disease rates.[12] In contrast, replacing carbohydrates with unsaturated fats or protein, as in the OMNIHeart trial, further lowers LDL-C and prevents increases in TGs.[11][13] Clinicians should provide clear guidance by distinguishing evidence-based dietary patterns with demonstrated cardiovascular benefits from popular dietary trends that lack outcome data.[14]
Adherence and Sustainability
Long-term adherence remains a major barrier to effective dietary therapy. Strict interventions, such as purely plant-based diets paired with aggressive lifestyle changes, can reduce LDL-C by up to 20%. However, adherence over the medium- to long-term is generally poor, particularly in primary prevention populations, thereby limiting their real-world effectiveness.[15] Less resource-intensive approaches can improve sustainability without sacrificing efficacy. For example, a portfolio dietary intervention requiring only 2 clinic visits achieved LDL-C reductions comparable to those from more intensive counseling involving 7 visits, highlighting the feasibility of pragmatic strategies.[16]
Other factors influencing adherence include restrictive or prescriptive messaging, cultural food preferences, food access, and socioeconomic constraints. Flexible dietary strategies that allow for personalization, cultural relevance, and gradual change are more likely to support long-term reductions in atherosclerotic cardiovascular disease (ASCVD) risk. Recent guidance emphasizes aligning dietary therapy with patient goals and quality-of-life considerations to enhance sustained engagement.
Modest Effects Compared to Pharmacotherapy
When optimally implemented, dietary therapy typically lowers LDL-C by 8% to 15%, substantially less than statins (20%–50% reduction) or Proprotein convertase subtilisin/kexin type 9 inhibitors (up to 60% reduction).[17] Clinicians must set realistic expectations for patients who require pharmacotherapy and consider dietary treatment as a complementary strategy in those cases. Based on limited and inconsistent data showing benefit in lowering lipids and reducing ASCVD risk, current guidelines do not support the use of dietary supplements to lower LDL-C or triglycerides.[18]
Clinical Significance
The Impact of Dietary Patterns on LDL Cholesterol and Cardiometabolic Risk
Dietary modification is a clinically meaningful intervention for lowering LDL-C, with potential reductions of approximately 10% to 30%, depending on the dietary pattern, baseline LDL-C level, and adherence. One of the most effective dietary substitutions is replacing 5% of total energy from saturated fat with monounsaturated or polyunsaturated fat, which is associated with approximately 5% to 10% reductions in LDL-C. In 2016, the AHA recommended limiting saturated fat intake to less than 7% of total calories for the general population and to less than 6% for individuals at higher cardiovascular risk.[19][20]
The AHA modified its position for the general population in 2026, stating that heart-healthy dietary patterns are unlikely to exceed less than 10% of energy from saturated fat.[21] The Dietary Guidelines for Americans (2025–2030) recommend limiting saturated fat intake to 10% or less of daily calories, equivalent to approximately 22 g/day on a 2000-calorie diet (200 kcal, assuming 9 kcal/g of fat).[22][23] Replacing saturated fats with unsaturated fats is associated with improved LDL-C levels. The main sources of dietary saturated fat include red meats, butter, high-fat dairy products, coconut oil, and palm oil.
Unsaturated fats come from fish, nuts, flax and chia seeds, and oils, particularly corn, sunflower, and soybean oils. Monounsaturated fats are found in olive oil, canola oil, avocados, and nuts. Focusing on healthy eating patterns that limit saturated fats while increasing unsaturated fat intake yields more consistent LDL-C lowering than restricting dietary cholesterol.[3]
Comprehensive dietary intervention trials report mean reductions in LDL-C of 13% to 20%. Portfolio-style dietary patterns may yield even greater reductions under controlled conditions.[24][25] In addition to lowering lipids, dietary therapy improves overall diet quality and multiple cardiometabolic risk factors, including blood pressure, insulin sensitivity, blood glucose, and systemic inflammation. As such, dietary intervention remains a foundational component of cardiovascular risk reduction across diverse patient populations.[12]
The AHA's "Life's Essential 8" outlines a lifestyle management framework to optimize cardiovascular health, emphasizing healthy dietary patterns, regular physical activity, maintaining a healthy weight, adequate sleep, normal blood lipid and glucose levels, controlled blood pressure, and avoiding nicotine. This approach prioritizes whole-food eating patterns over individual nutrients. However, replacing saturated fats with sugary or ultra-processed foods can negate the benefits of reducing saturated fat intake.[26]
Plant-Based Dietary Patterns and LDL-C Reduction
Randomized controlled trials and observational studies consistently show an association between eating patterns, including the Mediterranean, DASH, and vegetarian diets, and improved cardiovascular outcomes.[27][28] Additional improvement in LDL-C is observed with vegetarian diets, particularly those that include added fiber, soy protein, and nuts.[29][30] The 2025 American Association of Clinical Endocrinology consensus statement recommends dietary patterns, including the Mediterranean diet, DASH, and healthful plant-based diets, to reduce ASCVD risk.[31] Similarly, the National Lipid Association endorses several evidence-based dietary patterns, including DASH, AHA, Mediterranean-style, and vegetarian or vegan diets, tailored to individual lipid abnormalities and cultural food preferences.[32] Most dietary patterns associated with LDL-C reduction are plant-based.
In the clinical literature, the terms "plant-based" or "plant-forward" refer to dietary patterns that emphasize plant foods such as vegetables, fruits, whole grains, legumes, nuts, and seeds, without necessarily excluding animal products. This category includes vegetarian and vegan diets, as well as cardiometabolic health–focused patterns such as the Mediterranean, DASH, and Nordic diets, as well as the dietary portfolio approach. Unlike vegetarian or vegan diets, which exclude meat or all animal products, respectively, several plant-based dietary patterns prioritize plant foods while allowing limited intake of animal products such as dairy, eggs, fish, and meat.[33][34]
The Mediterranean diet
The Mediterranean diet is characterized by a high intake of fruits, vegetables, whole grains, legumes, nuts, olive oil, and fish, with limited consumption of red and processed meats. This pattern consistently produces modest reductions in LDL-C and, more importantly, is associated with fewer primary and secondary cardiovascular events.[35][36] The favorable fat quality, high fiber intake, and a rich supply of bioactive compounds with anti-inflammatory and antioxidant properties likely account for these benefits.[37]
The DASH diet
The DASH diet, well established for reducing blood pressure and improving overall cardiometabolic risk, emphasizes fruits, vegetables, whole grains, low-fat dairy products, lean protein sources, and sodium restriction. Some studies show modest reductions in LDL-C; however, a 2025 Cochrane review found inconsistent effects on LDL-C across trials, underscoring the need for longer-term, well-designed randomized controlled trials. Despite this limitation, the DASH diet remains particularly appropriate for patients with hypertension or metabolic syndrome, in whom LDL-C management is also a priority.[38]
The dietary portfolio approach
The dietary portfolio approach is a structured, plant-based dietary pattern that combines 4 evidence-based cholesterol-lowering components: approximately 2 g/day of plant sterols (typically achieved through fortified foods), at least 10 g/day of viscous fiber (such as psyllium, oats, barley, and legumes), about 50 g/day of plant protein (with an emphasis on soy protein), and roughly 45 g/day of nuts. Consuming 2 g of plant sterols daily from natural foods alone is challenging and impractical, as it would require eating large amounts of sterol-rich foods, thereby increasing caloric intake. Clinical trials achieved this intake by incorporating plant sterol–enriched margarine, typically providing approximately 1 g of plant sterols per serving, allowing participants to reach 2 g/day without substantially increasing total caloric intake.[39] Controlled trials demonstrate LDL-C reductions ranging from 13% to 30%, with some cases approaching the magnitude of reductions achieved with first-generation statin therapy.[40]
The LDL-C–lowering effects of the dietary portfolio approach stem from complementary mechanisms. Plant sterols competitively inhibit intestinal cholesterol absorption, reducing uptake by about 10%. Viscous fibers bind bile acids, increasing fecal bile acid excretion and stimulating hepatic conversion of cholesterol to bile acids.[24][41] Plant proteins and nuts further contribute by providing favorable fatty acid profiles and bioactive compounds that improve lipid metabolism. Despite its efficacy, the dietary portfolio approach requires adherence to multiple prescriptive components, which may limit feasibility and long-term adherence in real-world settings.[17]
Other Plant-Based Dietary Patterns
Additional dietary patterns associated with LDL-C reduction include vegetarian, vegan, pescatarian, and Nordic diets. As with the other dietary patterns discussed throughout this topic, reduced saturated fat intake, increased soluble fiber intake, and greater reliance on minimally processed plant foods drive LDL-C lowering in these patterns. Variability in adherence and nutritional adequacy underscores the importance of individualized dietary counseling.
Across dietary patterns, the following mechanisms operate synergistically to improve LDL-C and overall ASCVD risk:
- Replacing saturated fats with monounsaturated and polyunsaturated fats
- Increasing soluble fiber intake from sources such as oats, legumes, and psyllium
- Incorporating nuts, seeds, and plant-based protein sources
- Limiting ultra-processed foods and refined carbohydrates, including white bread, white rice, pasta, pastries, sugary cereals, pizza, crackers, and other high-sugar foods
Populations with Enhanced Benefit
Dietary therapy tends to yield greater absolute LDL-C reductions in individuals with higher baseline LDL-C levels and in patients with obesity, metabolic syndrome, or type 2 diabetes. In these populations, improvements in insulin sensitivity and weight regulation may further enhance lipid-lowering effects.[42][43]
Hypertriglyceridemia
Dietary intervention is the first-line therapy for hypertriglyceridemia, and highly responsive individuals may experience more than a 70% reduction in triglycerides with intensive lifestyle modifications.[44][45] Treatment focuses on limiting added sugars, refined carbohydrates, saturated fats, and alcohol, all of which can markedly increase triglyceride levels. Recommendations should be individualized based on the degree of triglyceride elevation and the underlying clinical syndrome.[46][47] Referral to a registered dietitian nutritionist (RDN) is recommended for patients with triglycerides at 1000 mg/dL or less to develop a tailored nutrition plan to lower and triglycerides reduce pancreatitis risk, and for those with fasting triglycerides at 150 to 999 mg/dL and features of cardiovascular-kidney-metabolic syndrome (abdominal obesity, insulin-resistant glucose metabolism, dyslipidemia, elevated blood pressure, or kidney involvement) for counseling on evidence-based dietary patterns. Medical nutrition therapy by an RDN can help lower lipid levels in some patients and may reduce the burden of pharmacotherapy.[48]
Limits of Clinical Evidence
Although certain dietary patterns consistently improve lipid profiles and cardiometabolic risk factors, much of the evidence relies on surrogate endpoints rather than hard cardiovascular outcomes. For example, no randomized controlled trial has directly evaluated the impact of the dietary portfolio approach on cardiovascular events, despite its robust efficacy in lowering LDL-C.[17] Similarly, a recent Cochrane review of randomized controlled trials evaluating Mediterranean dietary interventions for primary prevention found low-certainty evidence of modest improvements in ASCVD risk factors, with uncertainty regarding reductions in hard clinical events.[49] These limitations highlight the need to incorporate dietary therapy into comprehensive ASCVD risk-reduction strategies while continuing to individualize care based on patient risk, preferences, and feasibility.
Clinical Integration
Primary prevention is most effective when healthy behaviors are established in childhood and sustained over time. Health behavior counseling to support lifestyle optimization should begin early because dietary factors influence the likelihood of developing dyslipidemia, and promoting heart-healthy eating patterns in childhood and adolescence is associated with a reduced risk.[4][50] Healthcare professionals should provide dietary counseling on eating patterns that improve lipid profiles and advocate for other lifestyle interventions, such as regular physical activity, weight management, and nicotine avoidance. The ACC and AHA recommend that adults engage in at least 150 min/wk of moderate-intensity aerobic activity or 75 min/wk of vigorous-intensity activity (or an equivalent combination) for both primary prevention and management of established ASCVD.[27][51] Dietary patterns rich in fruits, vegetables, whole grains, legumes, nuts, seeds, and unsaturated plant oils consistently improve LDL-C and reduce overall cardiometabolic risk, whereas processed meats and foods high in saturated or trans fats should be minimized.[52]
Enhancing Healthcare Team Outcomes
Nutrition therapy is a cornerstone of dyslipidemia management and cardiovascular disease prevention, complementing pharmacologic therapy by improving lipid profiles and reducing overall cardiometabolic risk. Contemporary evidence emphasizes dietary patterns rather than isolated nutrient restriction, prioritizing reduced saturated fat intake, replacement with unsaturated fats, increased dietary fiber intake, and consumption of minimally processed whole foods. Evidence-based dietary approaches, including the Mediterranean, DASH, plant-based, and dietary portfolio patterns, improve low-density lipoprotein cholesterol and other cardiovascular risk factors, although adherence and sustainability remain important determinants of long-term success. Individualized dietary counseling is essential, particularly for patients with hypertriglyceridemia, obesity, metabolic syndrome, diabetes, or elevated cardiovascular risk.
Effective nutrition therapy requires coordinated interprofessional care involving physicians, primary care clinicians, advanced practitioners, registered dietitian nutritionists, nurses, pharmacists, and other healthcare professionals. Clinicians should assess cardiovascular risk, lipid abnormalities, dietary habits, and readiness for behavior change, and integrate nutrition therapy with evidence-based pharmacologic treatment when indicated. Registered dietitian nutritionists provide individualized medical nutrition therapy, reinforce sustainable dietary patterns, and address cultural preferences, food access, and adherence barriers. Nurses support patient education, lifestyle counseling, monitoring, and follow-up, while pharmacists reinforce medication adherence, identify drug-nutrient interactions, and counsel patients receiving lipid-lowering therapy. Shared decision-making, coordinated communication, periodic reassessment of lipid parameters and cardiovascular risk, and timely referral to nutrition specialists promote long-term adherence, reduce preventable cardiovascular events, and improve patient-centered outcomes.
References
Virani SS, Morris PB, Agarwala A, Ballantyne CM, Birtcher KK, Kris-Etherton PM, Ladden-Stirling AB, Miller M, Orringer CE, Stone NJ. 2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia: A Report of the American College of Cardiology Solution Set Oversight Committee. Journal of the American College of Cardiology. 2021 Aug 31:78(9):960-993. doi: 10.1016/j.jacc.2021.06.011. Epub 2021 Jul 28 [PubMed PMID: 34332805]
Level 3 (low-level) evidenceBallena-Caicedo J, Zuzunaga-Montoya FE, Loayza-Castro JA, Vásquez-Romero LEM, Tapia-Limonchi R, De Carrillo CIG, Vera-Ponce VJ. Global prevalence of dyslipidemias in the general adult population: a systematic review and meta-analysis. Journal of health, population, and nutrition. 2025 Aug 26:44(1):308. doi: 10.1186/s41043-025-01054-3. Epub 2025 Aug 26 [PubMed PMID: 40859400]
Level 1 (high-level) evidenceWang Y, Xu D. Effects of aerobic exercise on lipids and lipoproteins. Lipids in health and disease. 2017 Jul 5:16(1):132. doi: 10.1186/s12944-017-0515-5. Epub 2017 Jul 5 [PubMed PMID: 28679436]
Klančar G, Grošelj U, Kovač J, Bratanič N, Bratina N, Trebušak Podkrajšek K, Battelino T. Universal Screening for Familial Hypercholesterolemia in Children. Journal of the American College of Cardiology. 2015 Sep 15:66(11):1250-1257. doi: 10.1016/j.jacc.2015.07.017. Epub [PubMed PMID: 26361156]
Writing Committee Members, Blumenthal RS, Morris PB, Gaudino M, Johnson HM, Anderson TS, Bittner VA, Blankstein R, Brewer LC, Cho L, de Ferranti SD, Gianos E, Gluckman TJ, Gradney KF, Isiadinso I, Lloyd-Jones DM, Marrs JC, Martin SS, McLain KH, Mehta LS, Mora S, Mulugeta WM, Natarajan P, Navar AM, Orringer CE, Polonsky TS, Reynolds HR, Saseen JJ, Shapiro MD, Soffer DE, Tynes SA, Villavaso CD, Virani SS, Wilkins JT. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2026 Apr 28:153(17):e1154-e1276. doi: 10.1161/CIR.0000000000001423. Epub 2026 Mar 13 [PubMed PMID: 41824552]
Level 1 (high-level) evidenceAmerican Heart Association Nutrition Committee, Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, Franklin B, Kris-Etherton P, Harris WS, Howard B, Karanja N, Lefevre M, Rudel L, Sacks F, Van Horn L, Winston M, Wylie-Rosett J. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation. 2006 Jul 4:114(1):82-96 [PubMed PMID: 16785338]
Lichtenstein AH, Appel LJ, Vadiveloo M, Hu FB, Kris-Etherton PM, Rebholz CM, Sacks FM, Thorndike AN, Van Horn L, Wylie-Rosett J. 2021 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association. Circulation. 2021 Dec 7:144(23):e472-e487. doi: 10.1161/CIR.0000000000001031. Epub 2021 Nov 2 [PubMed PMID: 34724806]
Carson JAS, Lichtenstein AH, Anderson CAM, Appel LJ, Kris-Etherton PM, Meyer KA, Petersen K, Polonsky T, Van Horn L, American Heart Association Nutrition Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Peripheral Vascular Disease; and Stroke Council. Dietary Cholesterol and Cardiovascular Risk: A Science Advisory From the American Heart Association. Circulation. 2020 Jan 21:141(3):e39-e53. doi: 10.1161/CIR.0000000000000743. Epub 2019 Dec 16 [PubMed PMID: 31838890]
Sacks FM, Lichtenstein AH, Wu JHY, Appel LJ, Creager MA, Kris-Etherton PM, Miller M, Rimm EB, Rudel LL, Robinson JG, Stone NJ, Van Horn LV, American Heart Association. Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association. Circulation. 2017 Jul 18:136(3):e1-e23. doi: 10.1161/CIR.0000000000000510. Epub 2017 Jun 15 [PubMed PMID: 28620111]
Nestel PJ, Mori TA. Dietary patterns, dietary nutrients and cardiovascular disease. Reviews in cardiovascular medicine. 2022 Jan 14:23(1):17. doi: 10.31083/j.rcm2301017. Epub [PubMed PMID: 35092209]
Welty FK. Dietary treatment to lower cholesterol and triglyceride and reduce cardiovascular risk. Current opinion in lipidology. 2020 Aug:31(4):206-231. doi: 10.1097/MOL.0000000000000689. Epub [PubMed PMID: 32692035]
Level 3 (low-level) evidenceClifton PM. Diet, exercise and weight loss and dyslipidaemia. Pathology. 2019 Feb:51(2):222-226. doi: 10.1016/j.pathol.2018.10.013. Epub 2018 Dec 7 [PubMed PMID: 30528924]
Ference BA, Graham I, Tokgozoglu L, Catapano AL. Reprint of: Impact of Lipids on Cardiovascular Health: JACC Health Promotion Series. Journal of the American College of Cardiology. 2018 Dec 11:72(23 Pt B):2980-2995. doi: 10.1016/j.jacc.2018.10.021. Epub [PubMed PMID: 30522632]
Dinu M, Abbate R, Gensini GF, Casini A, Sofi F. Vegetarian, vegan diets and multiple health outcomes: A systematic review with meta-analysis of observational studies. Critical reviews in food science and nutrition. 2017 Nov 22:57(17):3640-3649. doi: 10.1080/10408398.2016.1138447. Epub [PubMed PMID: 26853923]
Level 1 (high-level) evidenceCicero AFG, Fogacci F, Zambon A. Red Yeast Rice for Hypercholesterolemia: JACC Focus Seminar. Journal of the American College of Cardiology. 2021 Feb 9:77(5):620-628. doi: 10.1016/j.jacc.2020.11.056. Epub [PubMed PMID: 33538260]
Jenkins DJ, Jones PJ, Lamarche B, Kendall CW, Faulkner D, Cermakova L, Gigleux I, Ramprasath V, de Souza R, Ireland C, Patel D, Srichaikul K, Abdulnour S, Bashyam B, Collier C, Hoshizaki S, Josse RG, Leiter LA, Connelly PW, Frohlich J. Effect of a dietary portfolio of cholesterol-lowering foods given at 2 levels of intensity of dietary advice on serum lipids in hyperlipidemia: a randomized controlled trial. JAMA. 2011 Aug 24:306(8):831-9. doi: 10.1001/jama.2011.1202. Epub [PubMed PMID: 21862744]
Level 1 (high-level) evidenceNestel PJ, Mori TA. A Review of Low-Density Lipoprotein-Lowering Diets in the Age of Anti-Sense Technology. Nutrients. 2023 Mar 1:15(5):. doi: 10.3390/nu15051249. Epub 2023 Mar 1 [PubMed PMID: 36904248]
Blumenthal RS, Morris PB, Gaudino M, Johnson HM, Anderson TS, Bittner VA, Blankstein R, Brewer LC, Cho L, de Ferranti SD, Gianos E, Gluckman TJ, Gradney KF, Isiadinso I, Lloyd-Jones DM, Marrs JC, Martin SS, McLain KH, Mehta LS, Mora S, Mulugeta WM, Natarajan P, Navar AM, Orringer CE, Polonsky TS, Reynolds HR, Saseen JJ, Shapiro MD, Soffer DE, Tynes SA, Villavaso CD, Virani SS, Wilkins JT. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2026 May 19:87(19):2624-2757. doi: 10.1016/j.jacc.2025.11.016. Epub 2026 Mar 13 [PubMed PMID: 41824590]
Level 1 (high-level) evidenceVirani SS, Newby LK, Arnold SV, Bittner V, Brewer LC, Demeter SH, Dixon DL, Fearon WF, Hess B, Johnson HM, Kazi DS, Kolte D, Kumbhani DJ, LoFaso J, Mahtta D, Mark DB, Minissian M, Navar AM, Patel AR, Piano MR, Rodriguez F, Talbot AW, Taqueti VR, Thomas RJ, van Diepen S, Wiggins B, Williams MS, Peer Review Committee Members. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2023 Aug 29:148(9):e9-e119. doi: 10.1161/CIR.0000000000001168. Epub 2023 Jul 20 [PubMed PMID: 37471501]
Level 1 (high-level) evidenceVan Horn L, Carson JA, Appel LJ, Burke LE, Economos C, Karmally W, Lancaster K, Lichtenstein AH, Johnson RK, Thomas RJ, Vos M, Wylie-Rosett J, Kris-Etherton P, American Heart Association Nutrition Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; and Stroke Council. Recommended Dietary Pattern to Achieve Adherence to the American Heart Association/American College of Cardiology (AHA/ACC) Guidelines: A Scientific Statement From the American Heart Association. Circulation. 2016 Nov 29:134(22):e505-e529 [PubMed PMID: 27789558]
Lichtenstein AH, Khera A, Anderson CAM, Appel LJ, DeSilva DM, Gardner C, Hu FB, Jones DW, Petersen KS, American Heart Association. 2026 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association. Circulation. 2026 Mar 31:():. doi: 10.1161/CIR.0000000000001435. Epub 2026 Mar 31 [PubMed PMID: 41914202]
Snetselaar LG, de Jesus JM, DeSilva DM, Stoody EE. Dietary Guidelines for Americans, 2020-2025: Understanding the Scientific Process, Guidelines, and Key Recommendations. Nutrition today. 2021 Nov-Dec:56(6):287-295. doi: 10.1097/NT.0000000000000512. Epub 2021 Nov 12 [PubMed PMID: 34987271]
Level 3 (low-level) evidenceMozaffarian D. The 2025-2030 Dietary Guidelines for Americans. JAMA. 2026 Feb 17:335(7):575-577. doi: 10.1001/jama.2026.0283. Epub [PubMed PMID: 41533498]
Chiavaroli L, Nishi SK, Khan TA, Braunstein CR, Glenn AJ, Mejia SB, Rahelić D, Kahleová H, Salas-Salvadó J, Jenkins DJA, Kendall CWC, Sievenpiper JL. Portfolio Dietary Pattern and Cardiovascular Disease: A Systematic Review and Meta-analysis of Controlled Trials. Progress in cardiovascular diseases. 2018 May-Jun:61(1):43-53. doi: 10.1016/j.pcad.2018.05.004. Epub 2018 May 26 [PubMed PMID: 29807048]
Level 1 (high-level) evidenceClifton P, Colquhoun D, Hewat C, Jones P, Litt J, Noakes M, O'Brien R, Shrapnel B, Skeaff M. Dietary intervention to lower serum cholesterol. Australian family physician. 2009 Jun:38(6):424-9 [PubMed PMID: 19521587]
Lloyd-Jones DM, Allen NB, Anderson CAM, Black T, Brewer LC, Foraker RE, Grandner MA, Lavretsky H, Perak AM, Sharma G, Rosamond W, American Heart Association. Life's Essential 8: Updating and Enhancing the American Heart Association's Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association. Circulation. 2022 Aug 2:146(5):e18-e43. doi: 10.1161/CIR.0000000000001078. Epub 2022 Jun 29 [PubMed PMID: 35766027]
Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, Michos ED, Miedema MD, Muñoz D, Smith SC Jr, Virani SS, Williams KA Sr, Yeboah J, Ziaeian B. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2019 Sep 10:74(10):e177-e232. doi: 10.1016/j.jacc.2019.03.010. Epub 2019 Mar 17 [PubMed PMID: 30894318]
Level 1 (high-level) evidenceRaitakari O, Kartiosuo N, Pahkala K, Hutri-Kähönen N, Bazzano LA, Chen W, Urbina EM, Jacobs DR Jr, Sinaiko A, Steinberger J, Burns T, Daniels SR, Venn A, Woo JG, Dwyer T, Juonala M, Viikari J. Lipoprotein(a) in Youth and Prediction of Major Cardiovascular Outcomes in Adulthood. Circulation. 2023 Jan 3:147(1):23-31. doi: 10.1161/CIRCULATIONAHA.122.060667. Epub 2022 Nov 28 [PubMed PMID: 36440577]
Kirk EP, Klein S. Pathogenesis and pathophysiology of the cardiometabolic syndrome. Journal of clinical hypertension (Greenwich, Conn.). 2009 Dec:11(12):761-5. doi: 10.1111/j.1559-4572.2009.00054.x. Epub [PubMed PMID: 20021538]
Writing Committee, Lloyd-Jones DM, Morris PB, Ballantyne CM, Birtcher KK, Covington AM, DePalma SM, Minissian MB, Orringer CE, Smith SC Jr, Waring AA, Wilkins JT. 2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution Set Oversight Committee. Journal of the American College of Cardiology. 2022 Oct 4:80(14):1366-1418. doi: 10.1016/j.jacc.2022.07.006. Epub 2022 Aug 25 [PubMed PMID: 36031461]
Level 3 (low-level) evidencePatel SB, Belalcazar LM, Afreen S, Balderas R, Hegele RA, Karpe F, Ponte-Negretti CI, Rajpal A. American Association of Clinical Endocrinology Consensus Statement: Algorithm for Management of Adults with Dyslipidemia - 2025 Update. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2025 Oct:31(10):1207-1238. doi: 10.1016/j.eprac.2025.07.014. Epub 2025 Sep 12 [PubMed PMID: 40938233]
Level 3 (low-level) evidenceJacobson TA, Maki KC, Orringer CE, Jones PH, Kris-Etherton P, Sikand G, La Forge R, Daniels SR, Wilson DP, Morris PB, Wild RA, Grundy SM, Daviglus M, Ferdinand KC, Vijayaraghavan K, Deedwania PC, Aberg JA, Liao KP, McKenney JM, Ross JL, Braun LT, Ito MK, Bays HE, Brown WV, Underberg JA, NLA Expert Panel. National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2. Journal of clinical lipidology. 2015 Nov-Dec:9(6 Suppl):S1-122.e1. doi: 10.1016/j.jacl.2015.09.002. Epub 2015 Sep 18 [PubMed PMID: 26699442]
Kent G, Kehoe L, Flynn A, Walton J. Plant-based diets: a review of the definitions and nutritional role in the adult diet. The Proceedings of the Nutrition Society. 2022 Mar:81(1):62-74. doi: 10.1017/S0029665121003839. Epub 2021 Dec 20 [PubMed PMID: 35760588]
Yannakoulia M, Scarmeas N. Diets. The New England journal of medicine. 2024 Jun 13:390(22):2098-2106. doi: 10.1056/NEJMra2211889. Epub [PubMed PMID: 38865662]
Estruch R, Ros E, Salas-Salvadó J, Covas MI, Corella D, Arós F, Gómez-Gracia E, Ruiz-Gutiérrez V, Fiol M, Lapetra J, Lamuela-Raventos RM, Serra-Majem L, Pintó X, Basora J, Muñoz MA, Sorlí JV, Martínez JA, Fitó M, Gea A, Hernán MA, Martínez-González MA, PREDIMED Study Investigators. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. The New England journal of medicine. 2018 Jun 21:378(25):e34. doi: 10.1056/NEJMoa1800389. Epub 2018 Jun 13 [PubMed PMID: 29897866]
Karam G, Agarwal A, Sadeghirad B, Jalink M, Hitchcock CL, Ge L, Kiflen R, Ahmed W, Zea AM, Milenkovic J, Chedrawe MA, Rabassa M, El Dib R, Goldenberg JZ, Guyatt GH, Boyce E, Johnston BC. Comparison of seven popular structured dietary programmes and risk of mortality and major cardiovascular events in patients at increased cardiovascular risk: systematic review and network meta-analysis. BMJ (Clinical research ed.). 2023 Mar 29:380():e072003. doi: 10.1136/bmj-2022-072003. Epub 2023 Mar 29 [PubMed PMID: 36990505]
Level 1 (high-level) evidenceGardner CD, Vadiveloo MK, Petersen KS, Anderson CAM, Springfield S, Van Horn L, Khera A, Lamendola C, Mayo SM, Joseph JJ, American Heart Association Council on Lifestyle and Cardiometabolic Health. Popular Dietary Patterns: Alignment With American Heart Association 2021 Dietary Guidance: A Scientific Statement From the American Heart Association. Circulation. 2023 May 30:147(22):1715-1730. doi: 10.1161/CIR.0000000000001146. Epub 2023 Apr 27 [PubMed PMID: 37128940]
Bensaaud A, Seery S, Gibson I, Jones J, Flaherty G, McEvoy JW, Jordan F, Tawfick W, Sultan SA. Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases. The Cochrane database of systematic reviews. 2025 May 6:5(5):CD013729. doi: 10.1002/14651858.CD013729.pub2. Epub 2025 May 6 [PubMed PMID: 40326569]
Level 1 (high-level) evidenceWitkowska AM, Waśkiewicz A, Zujko ME, Mirończuk-Chodakowska I, Cicha-Mikołajczyk A, Drygas W. Assessment of Plant Sterols in the Diet of Adult Polish Population with the Use of a Newly Developed Database. Nutrients. 2021 Aug 7:13(8):. doi: 10.3390/nu13082722. Epub 2021 Aug 7 [PubMed PMID: 34444882]
Kirkpatrick CF, Sikand G, Petersen KS, Anderson CAM, Aspry KE, Bolick JP, Kris-Etherton PM, Maki KC. Nutrition interventions for adults with dyslipidemia: A Clinical Perspective from the National Lipid Association. Journal of clinical lipidology. 2023 Jul-Aug:17(4):428-451. doi: 10.1016/j.jacl.2023.05.099. Epub 2023 Jun 2 [PubMed PMID: 37271600]
Level 3 (low-level) evidenceGlenn AJ, Guasch-Ferré M, Malik VS, Kendall CWC, Manson JE, Rimm EB, Willett WC, Sun Q, Jenkins DJA, Hu FB, Sievenpiper JL. Portfolio Diet Score and Risk of Cardiovascular Disease: Findings From 3 Prospective Cohort Studies. Circulation. 2023 Nov 28:148(22):1750-1763. doi: 10.1161/CIRCULATIONAHA.123.065551. Epub 2023 Oct 25 [PubMed PMID: 37877288]
Chen M, Chen Q, Liu W, Tong H, Wu Y. The effectiveness of diet intervention in improving the metabolism of overweight and obese women: a systematic review and meta-analysis. American journal of translational research. 2022:14(5):2926-2938 [PubMed PMID: 35702099]
Level 1 (high-level) evidenceNeuenschwander M, Hoffmann G, Schwingshackl L, Schlesinger S. Impact of different dietary approaches on blood lipid control in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis. European journal of epidemiology. 2019 Sep:34(9):837-852. doi: 10.1007/s10654-019-00534-1. Epub 2019 Jun 14 [PubMed PMID: 31201670]
Level 1 (high-level) evidenceGrundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC Jr, Sperling L, Virani SS, Yeboah J. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2019 Jun 25:73(24):e285-e350. doi: 10.1016/j.jacc.2018.11.003. Epub 2018 Nov 10 [PubMed PMID: 30423393]
Level 1 (high-level) evidenceSilverman MG, Ference BA, Im K, Wiviott SD, Giugliano RP, Grundy SM, Braunwald E, Sabatine MS. Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis. JAMA. 2016 Sep 27:316(12):1289-97. doi: 10.1001/jama.2016.13985. Epub [PubMed PMID: 27673306]
Level 1 (high-level) evidenceVuorio A, Kuoppala J, Kovanen PT, Humphries SE, Tonstad S, Wiegman A, Drogari E, Ramaswami U. Statins for children with familial hypercholesterolemia. The Cochrane database of systematic reviews. 2019 Nov 7:2019(11):. doi: 10.1002/14651858.CD006401.pub5. Epub 2019 Nov 7 [PubMed PMID: 31696945]
Level 1 (high-level) evidencede Ferranti SD, Rodday AM, Mendelson MM, Wong JB, Leslie LK, Sheldrick RC. Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES). Circulation. 2016 Mar 15:133(11):1067-72. doi: 10.1161/CIRCULATIONAHA.115.018791. Epub [PubMed PMID: 26976914]
Level 3 (low-level) evidenceNuotio J, Laitinen TT, Magnussen CG, Sinaiko AR, Bazzano LA, Daniels SR, Jacobs DR Jr, Kartiosuo N, Koskinen J, Burgner DP, Kähönen M, Raitakari OT, Steinberger J, Urbina EM, Venn AJ, Viikari JSA, Woo JG, Dwyer T, Juonala M. Predictors in Youth of Adult Cardiovascular Events. Pediatrics. 2024 Nov 1:154(5):. doi: 10.1542/peds.2024-066736. Epub [PubMed PMID: 39397535]
Agarwala A, Petersen KS, Jafari F, Kris-Etherton PM. Dietary management of dyslipidemia and the impact of dietary patterns on lipid disorders. Progress in cardiovascular diseases. 2022 Nov-Dec:75():49-58. doi: 10.1016/j.pcad.2022.11.003. Epub 2022 Nov 19 [PubMed PMID: 36410416]
Luirink IK, Wiegman A, Kusters DM, Hof MH, Groothoff JW, de Groot E, Kastelein JJP, Hutten BA. 20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia. The New England journal of medicine. 2019 Oct 17:381(16):1547-1556. doi: 10.1056/NEJMoa1816454. Epub [PubMed PMID: 31618540]
Writing Committee Members, Virani SS, Newby LK, Arnold SV, Bittner V, Brewer LC, Demeter SH, Dixon DL, Fearon WF, Hess B, Johnson HM, Kazi DS, Kolte D, Kumbhani DJ, LoFaso J, Mahtta D, Mark DB, Minissian M, Navar AM, Patel AR, Piano MR, Rodriguez F, Talbot AW, Taqueti VR, Thomas RJ, van Diepen S, Wiggins B, Williams MS. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2023 Aug 29:82(9):833-955. doi: 10.1016/j.jacc.2023.04.003. Epub 2023 Jul 20 [PubMed PMID: 37480922]
Level 1 (high-level) evidence2020 Dietary Guidelines Advisory Committee, Dietary Patterns Subcommittee. Dietary Patterns and Risk of Cardiovascular Disease: A Systematic Review. 2020 Jul 15:(): [PubMed PMID: 35294140]
Level 1 (high-level) evidence